Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROVIDE: Personalized Immunotherapy in Sepsis
NCT03332225Phase 2Completed
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Start
- Dec 2017
- Primary completion
- Dec 2019
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of anakinra, interferon gamma-1b in sepsis, macrophage activation syndrome (MAS), sponsored by Hellenic Institute for the Study of Sepsis. Started Dec 2017; status: completed.
02
Drugs
anakinrainterferon gamma-1b
03
Conditions
sepsismacrophage activation syndrome (MAS)
Beyond the preview
Go deeper on NCT03332225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03332225.